INTERNATIONAL PATENT: JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD., 江苏康宁杰瑞生物制药有限公司 FILES APPLICATION FOR "COMBINATION OF PD-L1 BINDING MOLECULE AND PROTEIN-DRUG CONJUGATE AND USE THEREOF"

GENEVA, June 9 -- JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD. (No.175 Fangzhou Road, SIPSuzhou, Jiangsu 215000), 江苏康宁杰瑞生物制药有限公司 (中国江苏省苏州市苏州工业园区方洲路175号) filed a patent application (PCT/CN2024/135699) for "COMBINATION OF PD-L1 BINDING MOLECULE AND PROTEIN-DRUG CONJUGATE, AND USE THEREOF" on Nov 29, 2024. With publication no. WO/2025/113644, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system,...